In the crystal structure of the title compound, 2C 10 H 7 NO 4 Á-C 14 H 13 N 3 O 2 , the two independent acid molecules are connected through strong O-HÁ Á ÁN and O-HÁ Á ÁO hydrogen bonds to the central molecule of the antitubercular drug N 0 -[(E)-4-methoxybenzylidene]pyridine-4-carbohydrazide. Two such trimolecular units related by an inversion centre interact through a pair of N-HÁ Á ÁO hydrogen bonds, forming a 3 + 3 molecular aggregate. The dihedral angle between the aromatic rings of the hydrazone molecule is 1. 99 (12) . The crystal packing features weak C-HÁ Á ÁO and -stacking interactions, with centroid-centroid distances of 3.8460 (19) and 3.8703 (13) Å . Wardell et al. (2007) . For crystal structures with 2-(1,3-dioxoisoindolin-2-yl)acetic acid, see: Barooah et al. (2006); Feeder & Jones (1994 , 1996 . For a related co-crystal, see: Mohamed et al. (2012) . For the synthesis of 2-(1,3-dioxoisoindolin-2-yl)acetic acid, see: Rajpurohit & Sah (2005) .
Related literature

Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). et al., 2005) . In the present study we report the crystal structure of a novel, tricomponent cocrystal (I) containing the isoniazid-related hydrazone N′- [(E)-(4-methoxyphenyl) methylidene]pyridine-4-carbohydrazide and 2-(1,3-dioxoisoindolin-2-yl)acetic acid in a 1:2 molar ratio.
The asymmetric unit of (I) contains one hydrazone molecule and two crystallographically independent molecules of the acid denoted as A and B in Fig. 1 . The A and B molecules tightly connect to the hydrazone via short and directional O2a -H1Oa···N1 and O2b-H1Ob···O1 hydrogen bond, respectively ( Table 1) . The interactions of A and B molecules significantly differ as their carboxyl acid groups, serving as proton donors, find different acceptors within the hydrazone molecule i.e. pyridinyl N1 and carboxyl O1 (Fig. 1) . The interaction O2a-H1Oa···N1 which directly involves the acidic -COOH group and the most basic pyridinyl N1 atom causes the noticeable elongation of O2-H1Oa bond in molecule A (Table 1 ), yet no proton transfer occurs and all components remain neutral.
Besides the different engagement in the strongest interactions, the important difference between molecules A and B concerns their conformation. Thus the O1 carbonyl atom adopts trans and cis orientation relating to N1 atom in A and B.
In addition, the O1-C1-C2-N1 torsion angle is 161.2 (2) and 1.4 (2)°, in molecules A and B respectively. It is worth mentioning that in a previously reported cocrystal (Mohamed et al., 2012) as well as in the crystal structures of 2-(1,3-dioxoisoindolin-2-yl)acetic acid containing one molecule in the asymmetric unit (Feeder & Jones, 1996) , two independent molecules (Barooah et al., 2006) or the same molecule as monohydrate (Feeder & Jones, 1994) , the value of the corresponding torsion angle O1-C1-C2-N1 is below 15.8° indicating the preferred conformation is similar to that of molecule B.
There are several crystal structures of hydrazone N′- [(E)-(4-methoxyphenyl) methylidene]pyridine-4-carbohydrazide describing this compound as monohydrate crystallizing in two forms, monoclinic (Jing et al., 2005; Shanmuga Sundara Raj et al., 1999; Wardell et al., 2007) and orthorhombic (Lin & Liu, 2007) . The present form of the molecule shows no particular difference in bond lengths and angles in comparison to the previous ones.
The above described trimer with strongly intermolecular hydrogen-bonded components ( Fig. 1) , undergoes further arrangement via much weaker interamolecular interactions. Two such trimolecular units related by an inversion centre interact through a pair of N2-H1N2···O4b hydrogen bonds ( Apart from this classical N-H···O hydrogen bond, the arrangement of the molecules in the cocrystal is further based on weak C-H···O (Table 1) 2-(1,3-Dioxoisoindolin-2-yl)acetic acid was prepared according to the literature procedure (Rajpurohit & Sah, 2005) . The molecular structure of the title compound with displacement ellipsoids drawn at the 35% probability level. 
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